SISLAN (Zhuhai) Pharmaceutical Technology Co., Ltd. was formally established
Release time:
2021-10-18
SISLAN (Nanyang) Pharmaceutical Co., Ltd., a wholly-owned subsidiary established by SISLAN (Zhuhai) Pharmaceutical Co., Ltd. in Zhuhai, officially settled in Hengqin International Science and Technology Innovation Center (China-Latin America Economic and Trade Cooperation Park). How much do you know about Hengqin New District?
1
The Hengqin New Area was established in 2009 and the Hengqin Free Trade Area was officially listed in 2015. It is a major cooperation platform for the Guangdong-Hong Kong-Macao Greater Bay Area, focusing on the development of technological innovation, characteristic finance, medical and health, cross-border commerce, cultural tourism exhibitions, professional services, etc. industry.
2
On December 20, 2019, General Secretary Xi Jinping clearly instructed at the meeting celebrating the 20th anniversary of Macao's return to the motherland: "at present, we should especially do a good job in the article on the cooperation between Zhuhai and Macao in the development of Hengqin, so as to open up a broad space and inject new impetus into Macao's long-term development".
3
After 11 years of development and construction, Hengqin New District has achieved a cumulative investment in fixed assets of more than 315 billion yuan. At present, Hengqin has developed from a small border island with "banana forests and green fields, and few farms" to a modern new city with rapid changes. Today, Hengqin has a superior ecological environment, Complete infrastructure and diverse cultural life provide an excellent investment environment for investors from home and abroad.
Company Profile
SISLAN (Zhuhai) Pharmaceutical Technology Co., Ltd. has a registered capital of 10 million yuan. The company is a research and development and sales company of traditional Chinese medicine preparation products and large-scale health products. Currently, it plans to sign a drug research and development project with Guangzhou University of Traditional Chinese Medicine and Zhengzhou University. It is planned to invest 80 million yuan in the research and development of drugs and large-scale health products within three years, through 5-10 years of efforts, the company will be built into an enterprise that uses modern technology to engage in the research and development, production and sales of drugs, cosmetics and medical devices.
Recommend Content
Share
Contact Information
Telephone:+86 0377-6169 3188
E-mail:office@sislan.cn
Address: South End of Beijing Avenue, Nanyang City, Henan Province
Copyright© SISLAN (Nanyang) Pharmaceutical Co., Ltd.
SAF Coolest v1.3.1.2 设置面板 XSYSD-ZEHE-FXSVE-EWS
无数据提示
Sorry, the current column is being updated, please look forward to it!
You can view other columns or returnHome Page